NEONC TECHNOLOGIES HOLDINGS, INC. Amortization of Debt Issuance Costs
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Amortization of Debt Issuance Costs of $167.95 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $167.95K, a 12.64% decline year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2026-03-31 was $192.16K, a 14.42% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $312.17K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $438.11K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for fiscal 2025 was $1.11M, a 665.34% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization of debt issuance costs for fiscal 2024 was $145.10K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $167.95K 10-Q · filed 2026-08-10 | $360.12K 10-Q · filed 2026-08-10 | $672.29K derived: sum of 3 quarters · filed 2026-08-10 | $1.11M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $192.16K 10-Q · filed 2026-05-15 | $504.34K derived: sum of 2 quarters · filed 2026-05-15 | $942.45K derived: sum of 3 quarters · filed 2026-05-15 | $1.13M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $312.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $750.28K derived: sum of 2 quarters · filed 2026-03-31 | $942.53K derived: sum of 3 quarters · filed 2026-08-10 | $1.11M 10-K · filed 2026-03-31 |
| 2025-09-30 | $438.11K 10-Q · filed 2025-11-14 | $630.36K derived: sum of 2 quarters · filed 2026-08-10 | $798.31K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $192.25K 10-Q · filed 2026-08-10 | $360.20K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $167.95K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $145.10K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |